The plan, which is not finalized, suggests children get fewer shots and shifts to a model telling parents to consult doctors ...
If the U.S. were to match Denmark’s selections, it would mean fewer recommended vaccines for American children. The U.S.
The FDA has been rumored to be evaluating whether or not to place a black box warning on vaccines for COVID-19.
The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership ...
After patient deaths from interstitial lung disease in a lung cancer trial testing the antibody-drug conjugate ifinatamab deruxtecan, the FDA placed a partial hold on Daiichi Sankyo and Merck's global ...
A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...
As 2025 closes, biopharma and healthcare are learning to live on shifting ground. | Fierce reporters break down the forces that shaped biopharma and healthcare in 2025 and what lies ahead in 2026.
The Trump administration has announced sweeping policies that, if enacted, could effectively end gender-affirming care for ...
UNC's Barry Popkin joins Aaron to discuss the health impacts of "ultra-processed foods" and what policymakers should be doing ...
Biostatistician Jeffrey Morris discusses his analysis of the vaccine monitoring system — and how it could be improved.
A recent memo from Dr. Vinay Prasad, the head of the FDA's Center for Biologics Evaluation and Research, may signal an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback